IgE-activated mast cells generate a large number of cytokines that have proinflammatory and immunoregulatory capabilities that are likely to affect processes that occur in bronchial asthma. However, little is known about the regulation of cytokine production in mast cells. Therefore, the first Specific Aim of this Project will determine the effects of mast cell-regulatory cytokines such as KL, IL-4, IL-9, and IL- 10 on basal and IgE-elicited increases in mast cell-produced cytokines. Immature mast cells cultured from mouse bone marrow in recombinant IL-3 will be exposed to mast cell-regulatory cytokines and their effects on mast cell-produced cytokine transcripts and proteins will be assessed by RNA blots and ELISA analyses, respectively. The contributions of de novo transcription and changes in transcript stability to the steady-state levels of mast cell-produced cytokine transcripts will be assessed by nuclear run-on and Actinomycin D mRNA half-life studies, respectively. The fraction of each mast cell population producing a particular cytokine and the spectrum of cytokines that individual mast cells can make will be assessed by in situ hybridization and immunocytochemistry, respectively. Moreover, the latter two technologies will also be used to assess cytokine production by mature serosal mast cells isolated from the mouse peritoneal cavity, and to study the effects of mast cell regulatory-cytokines on these cells ex vivo. The second Specific Aim of this Project is to determine whether the ability of the immunosuppressive agent FK506 to inhibit cytokine production in IgE-activated mast cells is influenced by the stage of mast cell development and the expression of an intracellular FK506-binding protein, FKBP12. FK506 prevents cytokine transcription in T cells, but immature IL-3-dependent bone marrow culture-derived mast cells are resistant to FK506 and are concomitantly deficient in FKBP12. Using RNA and protein immunoblot techniques, we will measure the expression of FKBP12 and other FK506- binding proteins in mature serosal mast cells and in bone marrow-derived mast cells cultured in mast cell-regulatory cytokines. The ability of FK506 to inhibit IgE-mediated increases in steady-state levels of cytokine transcripts and FKBP12-dependent inhibition of calcineurin phosphatase activity (a target of the FK506-FKBP12 complex) will be measured as functional readouts to be related to the expression of FKBP12 in the mast cells. Finally, mast cell lines transfected to overexpress particular FKBPs will be assessed functionally to link definitively FKBP12 expression with FK506-mediated inhibition of cytokine production in activated mast cells. Overall, the studies in this project are expected to reveal new aspects about the regulation of the production and pharmacologic inhibition of mast cell-produced cytokines.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
Liu, Tao; Barrett, Nora A; Kanaoka, Yoshihide et al. (2018) Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity. J Immunol 200:915-927
Liu, Tao; Garofalo, Denise; Feng, Chunli et al. (2015) Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors. J Immunol 194:5061-8
Laidlaw, Tanya M; Cutler, Anya J; Kidder, Molly S et al. (2014) Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 133:1692-701.e3
Fanning, Laura B; Buckley, Carolyn C; Xing, Wei et al. (2013) Downregulation of key early events in the mobilization of antigen-bearing dendritic cells by leukocyte immunoglobulin-like Receptor B4 in a mouse model of allergic pulmonary inflammation. PLoS One 8:e57007
Ohta, Shin; Imamura, Mitsuru; Xing, Wei et al. (2013) Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation. J Immunol 190:5927-38
Cummings, Hannah E; Liu, Tao; Feng, Chunli et al. (2013) Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor. J Immunol 191:5807-10
Liu, Tao; Laidlaw, Tanya M; Katz, Howard R et al. (2013) Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci U S A 110:16987-92
Laidlaw, Tanya M; Kidder, Molly S; Bhattacharyya, Neil et al. (2012) Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 119:3790-8
Simarro, Maria; Giannattasio, Giorgio; Xing, Wei et al. (2012) The translational repressor T-cell intracellular antigen-1 (TIA-1) is a key modulator of Th2 and Th17 responses driving pulmonary inflammation induced by exposure to house dust mite. Immunol Lett 146:8-14
Cozzi, Emily; Ackerman, Kate G; Lundequist, Anders et al. (2011) The naive airway hyperresponsiveness of the A/J mouse is Kit-mediated. Proc Natl Acad Sci U S A 108:12787-92

Showing the most recent 10 out of 200 publications